3 Stocks Pulling The Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 30 points (0.2%) at 16,949 as of Wednesday, Aug. 20, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,346 issues advancing vs. 1,589 declining with 185 unchanged.

The Health Services industry currently sits down 0.4% versus the S&P 500, which is up 0.1%. On the negative front, top decliners within the industry include Intuitive Surgical ( ISRG), down 1.1%, Waters ( WAT), down 1.0%, Agilent Technologies ( A), down 0.8%, Abbott Laboratories ( ABT), down 0.8% and WellPoint ( WLP), down 0.7%. A company within the industry that increased today was Express Scripts ( ESRX), up 0.6%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Varian Medical Systems ( VAR) is one of the companies pushing the Health Services industry lower today. As of noon trading, Varian Medical Systems is down $0.83 (-1.0%) to $83.86 on average volume. Thus far, 306,090 shares of Varian Medical Systems exchanged hands as compared to its average daily volume of 573,700 shares. The stock has ranged in price between $83.42-$84.66 after having opened the day at $84.39 as compared to the previous trading day's close of $84.69.

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy worldwide. Varian Medical Systems has a market cap of $8.8 billion and is part of the health care sector. Shares are up 9.0% year-to-date as of the close of trading on Tuesday. Currently there are 6 analysts that rate Varian Medical Systems a buy, 1 analyst rates it a sell, and none rate it a hold.

TheStreet Ratings rates Varian Medical Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, increase in stock price during the past year and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Varian Medical Systems Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Cooper Companies ( COO) is down $1.57 (-1.0%) to $160.28 on light volume. Thus far, 195,219 shares of Cooper Companies exchanged hands as compared to its average daily volume of 591,500 shares. The stock has ranged in price between $160.18-$162.37 after having opened the day at $161.16 as compared to the previous trading day's close of $161.85.

The Cooper Companies, Inc. operates as a medical device company worldwide. Cooper Companies has a market cap of $7.8 billion and is part of the health care sector. Shares are up 30.7% year-to-date as of the close of trading on Tuesday. Currently there are 7 analysts that rate Cooper Companies a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates Cooper Companies as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Cooper Companies Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, HCA Holdings ( HCA) is down $0.81 (-1.2%) to $67.88 on average volume. Thus far, 1.4 million shares of HCA Holdings exchanged hands as compared to its average daily volume of 3.3 million shares. The stock has ranged in price between $67.78-$68.48 after having opened the day at $68.35 as compared to the previous trading day's close of $68.69.

HCA Holdings, Inc., through its subsidiaries, provides health care services. HCA Holdings has a market cap of $29.8 billion and is part of the health care sector. Shares are up 44.0% year-to-date as of the close of trading on Tuesday. Currently there are 15 analysts that rate HCA Holdings a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates HCA Holdings as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, revenue growth, good cash flow from operations and growth in earnings per share. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full HCA Holdings Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Daimler Shares Rise After Record Mercedes-Benz Sales, Bullish Profit Outlook

Daimler Shares Rise After Record Mercedes-Benz Sales, Bullish Profit Outlook

Global Stocks Rise on Tech Resurgence; Dollar Past 3-Month High Ahead of Q1 GDP

Global Stocks Rise on Tech Resurgence; Dollar Past 3-Month High Ahead of Q1 GDP

AMD Rises Above the Competition; Loan Losses Mount for Big Banks -- ICYMI

AMD Rises Above the Competition; Loan Losses Mount for Big Banks -- ICYMI

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%